ProfileGDS4718 / 238452_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 34% 35% 32% 37% 37% 31% 31% 32% 34% 25% 28% 48% 31% 28% 33% 30% 34% 27% 25% 42% 34% 32% 24% 35% 32% 30% 21% 34% 25% 40% 36% 38% 40% 30% 55% 50% 43% 43% 44% 34% 29% 31% 44% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7201134
GSM549102patient 115, normal, homogenized [OPG study]4.7989335
GSM549104patient 119, normal, homogenized [OPG study]4.6293732
GSM549108patient 138, normal, homogenized [OPG study]4.8873737
GSM549119patient 077, normal, homogenized [OPG study]4.8379437
GSM549133patient 032, cancer, homogenized [OPG study]4.5256331
GSM549139patient 042, cancer, homogenized [OPG study]4.5530731
GSM549099patient 107, normal, homogenized [OPG study]4.6454332
GSM549109patient 139, normal, homogenized [OPG study]4.7166134
GSM549110patient 046, normal, homogenized [OPG study]4.3562425
GSM549114patient 063, normal, homogenized [OPG study]4.4336528
GSM549122patient 082, normal, homogenized [OPG study]5.3846548
GSM549134patient 033, cancer, homogenized [OPG study]4.5647231
GSM549136patient 036, cancer, homogenized [OPG study]4.4028128
GSM549140patient 044, cancer, homogenized [OPG study]4.6226933
GSM549111patient 047, normal, homogenized [OPG study]4.5113530
GSM549113patient 057, normal, homogenized [OPG study]4.674834
GSM549132patient 031, cancer, homogenized [OPG study]4.3879727
GSM549137patient 038, cancer, homogenized [OPG study]4.3356125
GSM549142patient 047, cancer, homogenized [OPG study]5.2372442
GSM549100patient 110, normal, homogenized [OPG study]4.7634
GSM549107patient 135, normal, homogenized [OPG study]4.6045432
GSM549115patient 068, normal, homogenized [OPG study]4.2592624
GSM549116patient 072, normal, homogenized [OPG study]4.7290635
GSM549120patient 078, normal, homogenized [OPG study]4.6160732
GSM549131patient 030, cancer, homogenized [OPG study]4.4985430
GSM549118patient 074, normal, homogenized [OPG study]4.1937821
GSM549129patient 027, cancer, homogenized [OPG study]4.7336634
GSM549123patient 088, normal, homogenized [OPG study]4.3452525
GSM549124patient 006, cancer, homogenized [OPG study]5.0205740
GSM549126patient 015, cancer, homogenized [OPG study]4.7821336
GSM549128patient 025, cancer, homogenized [OPG study]4.8834338
GSM549103patient 117, normal, homogenized [OPG study]5.0559840
GSM549117patient 073, normal, homogenized [OPG study]4.5066330
GSM549138patient 041, cancer, homogenized [OPG study]5.8284655
GSM549141patient 045, cancer, homogenized [OPG study]5.4789450
GSM549130patient 028, cancer, homogenized [OPG study]5.1472943
GSM549101patient 111, normal, homogenized [OPG study]5.1677243
GSM549105patient 128, normal, homogenized [OPG study]5.1857944
GSM549106patient 134, normal, homogenized [OPG study]4.6666434
GSM549112patient 048, normal, homogenized [OPG study]4.4739729
GSM549125patient 011, cancer, homogenized [OPG study]4.6151731
GSM549127patient 024, cancer, homogenized [OPG study]5.1909944
GSM549135patient 035, cancer, homogenized [OPG study]6.6468567